Gene Expression Profiling to Predict Outcome After Chemoradiation in Head and Neck Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 69, Issue 5, 2007, Pages 1544-1552

  Pramana, Jimmy ^a   Van den Brekel, Michiel W M ^a   van Velthuysen, Marie Louise F ^a   Wessels, Lodewijk F A ^a   Nuyten, Dimitry S ^a   Hofland, Ingrid ^a   Atsma, Douwe ^a   Pimentel, Nuno ^b   Hoebers, Frank J P ^a   Rasch, Coen R N ^a   Begg, Adrian C ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Chemoradiation; Gene expression profiling; Head and neck; Microarrays; Squamous cell carcinoma

Indexed keywords

BIOLOGICAL ORGANS; MICROARRAYS; ONCOLOGY; PATIENT TREATMENT; RADIOLOGY; TUMORS;

CHEMORADIATION; GENE EXPRESSION PROFILING; RADIOSENSITIVITY; SQUAMOUS CELL CARCINOMA;

GENE EXPRESSION;

CISPLATIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CONTROL; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RADIOSENSITIVITY; RNA EXTRACTION; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; PHARYNGEAL NEOPLASMS; RADIATION-SENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 36149001337     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.08.032     Document Type: Article

References (33)

1. Sankaranarayanan R., Masuyer E., Swaminathan R., et al. Head and neck cancer: A global perspective on epidemiology and prognosis. Anticancer Res 18 (1998) 4779-4786
2. Dubben H.H., Thames H.D., and Beck-Bornholdt H.P. Tumor volume: A basic and specific response predictor in radiotherapy. Radiother Oncol 47 (1998) 167-174
3. Mancuso A.A., Mukherji S.K., Schmalfuss I., et al. Preradiotherapy computed tomography as a predictor of local control in supraglottic carcinoma. J Clin Oncol 17 (1999) 631-637
4. van den Broek G.B., Rasch C.R., Pameijer F.A., et al. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma. Cancer 101 (2004) 1809-1817
5. van de Vijver M.J., He Y.D., Van't Veer L.J., et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347 (2002) 1999-2009
6. Singh D., Febbo P.G., Ross K., et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell 1 (2002) 203-209
7. Valk P.J., Verhaak R.G., Beijen M.A., et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 350 (2004) 1617-1628
8. Choi P., and Chen C. Genetic expression profiles and biologic pathway alterations in head and neck squamous cell carcinoma. Cancer 104 (2005) 1113-1128 (Erratum in: Cancer 2005;104:2532.)
9. Chung C.H., Parker J.S., Karaca G., et al. Molecular classification of head and neck squamous cell carcinomas using patterns of gene expression. Cancer Cell 5 (2004) 489-500
10. Chung C.H., Parker J.S., Ely K., et al. Gene expression profiles identify epithelial-to-mesenchymal transition and activation of nuclear factor-{kappa}B signaling as characteristics of a high-risk head and neck squamous cell carcinoma. Cancer Res 66 (2006) 8210-8218
11. O'Donnell R.K., Kupferman M., Wei S.J., et al. Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24 (2005) 1244-1251
12. Warner G.C., Reis P.P., Jurisica I., et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis. Int J Cancer 110 (2004) 857-868
13. Roepman P., Wessels L.F., Kettelarij N., et al. An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37 (2005) 182-186
14. Braakhuis B.J., Senft A., de Bree R., et al. Expression profiling and prediction of distant metastases in head and neck squamous cell carcinoma. J Clin Pathol 59 (2006) 1254-1260
15. Chang H.Y., Nuyten D.S., Sneddon J.B., et al. Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci U S A 102 (2005) 3738-3743
16. Chi J.T., Wang Z., Nuyten D.S., et al. Gene expression programs in response to hypoxia: Cell type specificity and prognostic significance in human cancers. PLoS Med 3 (2006) e47
17. Glinsky G.V., Berezovska O., and Glinskii A.B. Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest 115 (2005) 1503-1521
18. Carter S.L., Eklund A.C., Kohane I.S., et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38 (2006) 1043-1048
19. Balm A.J., Rasch C.R., Schornagel J.H., et al. High-dose superselective intra-arterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 26 (2004) 485-493
20. Rasch CR, Balm AJ, Kroger R, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer, early results of a Phase III Trial [abstract]. Presented at the American Head and Neck Society Annual Meeting, Chicago, August 2006;S016.
21. Roberts C.J., Nelson B., Marton M.J., et al. Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles. Science 287 (2000) 873-880
22. Subramanian A., Tamayo P., Mootha V.K., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 (2005) 15545-15550
23. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
24. Dobbins K., and Simon R. Sample size planning for developing classifiers using high-dimensional DNA microarray data. Biostatistics 8 (2007) 101-117
25. Torres-Roca J.F., Eschrich S., Zhao H., et al. Prediction of radiation sensitivity using a gene expression classifier. Cancer Res 65 (2005) 7169-7176
26. Rubin Grandis J., Melhem M.F., Gooding W.E., et al. Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst 90 (1998) 824-832
27. Ang K.K., Berkey B.A., Tu X., et al. Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma. Cancer Res 62 (2002) 7350-7356
28. Eriksen J.G., Steiniche T., Askaa J., et al. The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys 58 (2004) 561-566
29. Ang K.K., Andratschke N.H., and Milas L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys 58 (2004) 959-965
30. Prince M.E., Sivanandan R., Kaczorowski A., et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A 104 (2007) 973-978
31. Wen Q.H., Nishimura T., Miwa T., et al. Expression of EGF, EGFR and PCNA in laryngeal lesions. J Laryngol Otol 109 (1995) 630-636
32. Bentzen S.M., Atasoy B.M., Daley F.M., et al. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. J Clin Oncol 23 (2005) 5560-5567
33. Zgheib O., Huyen Y., DiTullio Jr. R.A., et al. ATM signaling and 53BP1. Radiother Oncol 76 (2005) 119-122